Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v2-FR
Language French French
Date Updated 2019-12-20 2018-09-07
Drug Identification Number 02248728 02248728
Brand name APO-ALENDRONATE APO-ALENDRONATE
Common or Proper name ALENDRONATE ALENDRONATE
Company Name APOTEX INC APOTEX INC
Ingredients ALENDRONIC ACID ALENDRONIC ACID
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 BLS 30 BLS
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-05-31 2019-02-01
Actual discontinuation date
Remaining supply date 2020-05-31 2019-02-01
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments